Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina Schniederjohann

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|October 18, 2024
Multiplexed Immunophenotyping of Lymphoma Tissue SamplesChristina Schniederjohann, Peter-Martin Bruch, Sascha Dietrich, et al.
Blood|May 28, 2024
CD20-bispecific antibodies improve response to CD19-CAR T cells in lymphoma in vitro and CLL in vivo modelsBerit J Brinkmann, Alessia Floerchinger, Christina Schniederjohann, et al.
Blood|February 26, 2026
Patient-Derived Lymphoma Spheroids Reveal Predictive Markers of Glofitamab Resistance in Relapsed/Refractory B-NHLPaul Marcoux, Fabien Gava, Marie Tosolini, et al.
Nature Cancer|March 26, 2026
Reprogramming of stroma-derived chemokine networks drives the loss of tissue organization in nodal B cell lymphomaFelix Czernilofsky, Anna Mathioudaki, Lea Jopp-Saile, et al.
The New England Journal of Medicine|November 26, 2024
Aggressive Lymphoma after CD19 CAR T-Cell TherapyGuido Kobbe, Monika Brüggemann, Ben-Niklas Baermann, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|October 18, 2024
Multiplexed Immunophenotyping of Lymphoma Tissue SamplesChristina Schniederjohann, Peter-Martin Bruch, Sascha Dietrich, et al.
Blood|May 28, 2024
CD20-bispecific antibodies improve response to CD19-CAR T cells in lymphoma in vitro and CLL in vivo modelsBerit J Brinkmann, Alessia Floerchinger, Christina Schniederjohann, et al.
Blood|February 26, 2026
Patient-Derived Lymphoma Spheroids Reveal Predictive Markers of Glofitamab Resistance in Relapsed/Refractory B-NHLPaul Marcoux, Fabien Gava, Marie Tosolini, et al.
Nature Cancer|March 26, 2026
Reprogramming of stroma-derived chemokine networks drives the loss of tissue organization in nodal B cell lymphomaFelix Czernilofsky, Anna Mathioudaki, Lea Jopp-Saile, et al.
The New England Journal of Medicine|November 26, 2024
Aggressive Lymphoma after CD19 CAR T-Cell TherapyGuido Kobbe, Monika Brüggemann, Ben-Niklas Baermann, et al.
Pageof 1